Status:
COMPLETED
Effect of Prone Position onV/Q Matching in Non-intubated Patients With COVID-19
Lead Sponsor:
Southeast University, China
Conditions:
Covid19
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
A prospective physiologic study, in participants with COVID-19-related pneumonia requiring supplemental oxygen (standard oxygen therapy or high-flow nasal cannula (HFNC)) less than 24 hours. The inves...
Detailed Description
Once enrolled, an EIT dedicated belt containing 16 electrodes was placed around the participant's chest at the fifth or sixth intercostal space and connected it to an EIT monitor (PulmoVista 500; Dräg...
Eligibility Criteria
Inclusion
- aged 18 to75 years
- admitted to intensive care unit with a confirmed diagnosis of COVID-19-related pneumonia
- requiring supplemental oxygen (standard oxygen therapy or high-flow nasal cannula (HFNC)) less than 24 hours,
- gave written or witnessed verbal informed consent.
Exclusion
- uncollaborative or had an altered mental status,
- New York Heart Association class above II
- history of severe chronic obstructive pulmonary disease
- Contraindications to the use of EIT (e.g., presence of pacemaker or chest surgical wounds dressing) or prone position (as decided by the attending physician)
- Impending intubation (on the basis of clinical judgment, including clinical and physiological parameters).
Key Trial Info
Start Date :
February 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04754113
Start Date
February 8 2021
End Date
January 15 2022
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ling Liu
Nanjing, Jiangsu, China, 210009